Academic Screening Workshop Agenda

Emory Chemical Biology Discovery Centre
Haian Fu, Professor and Director, Emory University, United States of America

Medicinal Chemistry Capabilities in Academic Drug Discovery: You have a hit…what's next?
Michael Walters, Director of Combinatorial Chemistry Laboratory, University of Minnesota, United States of America

The Sloan-Kettering Discovery Engine & Approach
Christophe Antczak, Assistant Director, Memorial Sloan Kettering Cancer Center, United States of America

High Throughput Flow Cytometry at the University of New Mexico Center for Molecular Discovery: Cellular and Molecular Targets in Multiplexed and Multiparameter Format
Larry Sklar, Director, University of New Mexico Health Sciences Center, United States of America

Coffee Break and Networking

Seven years of HTS/HCS at the University of Pittsburgh - it’s the Collaborations Baby
Paul Johnston, Research Associate Professor, University of Pittsburgh, United States of America

EU-OPENSCREEN, Chemical Keys for Life's Locks
Bahne Stechmann, Scientific Manager, Leibniz-Institut für Molekulare Pharmakologie, Germany

BARD: BioAssay Research Database
Christopher Austin, Director, National Institutes of Health, United States of America

Lunch, Poster Viewing and Networking

Expert Panel discussion on “Trends on enabling technologies & the future of academic screening”
John Watson, Director, Promega Corporation, United States of America

Panelists: Rathnam Chaguturu, SRI; Terry Riss, Promega; Jim Inglese, NIH; Larry Sklar, University of New Mexico; Paul Johnson, University of Pittsburg; Haian Fu, Emory; Michael Walters, Minnesota; Edward Hyde, Upenn; Christophe Antczak, MSKCC; Jennifer Smith, HMS; Bahne Stechmann, EU-OPENSCREEN; Donato Tedesco, Cellecta; Blake Anson, Cellular Dynamics International; Tim Cloutier, Perkin Elmer; Pavel Fomitchov, GE Healthcare Life Sciences

Drinks Reception

Open Innovation-based Public-Private Partnerships: Promise or Panacea for Precompetitive Drug Discovery Initiatives
Rathnam Chaguturu, Founder and CEO/Senior Director, SRI International, United States of America

Academic-Industry Partnerships, the Challenges of Advancing and Managing Innovation
Robert Zivin, Research Associate Professor, University of Miami, United States of America

An Industrial Perspective of HTS in Academia
Ricardo Macarron, Vice President, GlaxoSmithKline, United States of America

Integrating Target Validation, Drug Discovery and Chemical Biology
John Hayley, Senior Director, EMT, Biology, OSI Pharmaceuticals, United States of America

The Conrad Prebys Center for Chemical Genomics for Internal and Collaborative Pre-clinical Drug Discovery with Pharma Co/Biotech Partners – Lessons Learned and Best Practices
Thomas Chung, Director of Outreach/Project Manager, Sanford Burnham Medical Research Institute, United States of America

Coffee Break and Networking

Pre-Competitive Collaboration at the Structural Genomics Consortium
Peter Brown, Principal Investigator, University of Toronto, Canada

Promega’s New Outreach Program to Support Design of Assays Submitted to Academic Screening Centers
Terry Riss, Senior Product Manager, Cell Health, Promega Corporation, United States of America

GVK BIO as an Academic Partner - Value-added, High Quality, Cost-effective Enabler of Drug Discovery & Development
Mohan Thiruvazhi, Director, GVK Bio, India

Lunch, Poster Viewing and Networking

Expert panel discussion on “Should academia be doing drug discovery?”
Rathnam Chaguturu, Founder and CEO/Senior Director, SRI International, United States of America

Panelists: Hakim Djaballah, MSKCC; Jim Inglese, NIH; Robert Zivin, Johnson & Johnson; Mel Reichman, LIMR; Ricardo Macarron, GSK; David Epstein, OSI Pharmaceuticals; Mohan Thiruvazhi, GVK Bio; Peter Brown, University of Toronto; Thomas Chung, Burnham; Terry Riss, Promega

Workshop Ends